Erik R. Dubberke, MD, MSPH, of the Division of Infectious Diseases in the Department of Medicine at Washington University School of Medicine in St. Louis, describes in Infection Control & Hospital Epidemiology the components of a successful program to control and prevent Clostridium difficile infection (CDI).
While Dubberke acknowledges that "studies are needed to define the optimal prevention practices and to investigate novel prevention methods," he points to the wearing of gloves when caring for a patient with CDI as the single recommended practice that is graded "A-I" and thus shown to have good evidence to back it up.
Dubberke says that a study (Johnson S, Gerding DN, Olson MM, et al. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med 1990;88(2):137140) conducted prior to the advent of universal and standard precautions randomized four wards with similar baseline rates of CDI to provide standard of care or to conduct an educational intervention. The intervention consisted of an educational campaign instructing nurses to wear gloves when handling body fluids and stool. Boxes of gloves were placed at each patients bedside on the intervention wards. There was a statistically significant decrease in CDI incidence on the intervention wards, from 7.7 to 1.5 cases per 1,000 patient-days, and no significant change in CDI incidence on the control wards (from 5.7 to 4.2 cases per 1,000 patient-days). Point prevalence assessments of asymptomatic C. difficile carriage were conducted before and after the intervention, and there was a statistically significant decrease in the proportion of patients colonized with C. difficile on the intervention wards (from 27 percent to 9 percent of patients; ), but no significant difference on the control wards (from 17 percent to 10 percent of patients).
To read further, CLICK HERE.
Reference: Dubberke ER. Prevention of Healthcare-Associated Clostridium difficile Infection: What Works? Infect Control Hosp Epidemiol 2010;31:S38S41.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.